{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:45:37Z","timestamp":1781347537098,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803137"],"award-info":[{"award-number":["81803137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373476"],"award-info":[{"award-number":["82373476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173445"],"award-info":[{"award-number":["82173445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017367","name":"Research Fund for Young Star of Science and Technology in Shaanxi Province","doi-asserted-by":"publisher","award":["2024ZC-KJXX-084"],"award-info":[{"award-number":["2024ZC-KJXX-084"]}],"id":[{"id":"10.13039\/100017367","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Innovation Capability Support Plan of Shaanxi Health Commission","award":["2024TD-15"],"award-info":[{"award-number":["2024TD-15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05993-2","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T04:36:15Z","timestamp":1764218175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Transforming growth factor alpha promotes bullous pemphigoid pathogenesis by disrupting cell adhesion and inducing inflammation"],"prefix":"10.1007","volume":"83","author":[{"given":"Sijia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-1834","authenticated-orcid":false,"given":"Yale","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"5993_CR1","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","volume":"10","author":"G Genovese","year":"2019","unstructured":"Genovese G, Di Zenzo G, Cozzani E, Berti E, Cugno M, Marzano AV (2019) New insights into the pathogenesis of bullous pemphigoid: 2019 update. Front Immunol 10:1506. https:\/\/doi.org\/10.3389\/fimmu.2019.01506","journal-title":"Front Immunol"},{"key":"5993_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","volume":"11","author":"CM Hammers","year":"2016","unstructured":"Hammers CM, Stanley JR (2016) Mechanisms of disease: pemphigus and bullous pemphigoid. Annu Rev Pathol 11:175\u2013197. https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044313","journal-title":"Annu Rev Pathol"},{"key":"5993_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","volume":"16","author":"IS Ba\u011fc\u0131","year":"2017","unstructured":"Ba\u011fc\u0131 IS, Horv\u00e1th ON, Ruzicka T, S\u00e1rdy M (2017) Bullous pemphigoid. Autoimmun Rev 16:445\u2013455. https:\/\/doi.org\/10.1016\/j.autrev.2017.03.010","journal-title":"Autoimmun Rev"},{"key":"5993_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","volume":"18","author":"P Bernard","year":"2017","unstructured":"Bernard P, Antonicelli F (2017) Bullous pemphigoid: a review of its diagnosis, associations and treatment. Am J Clin Dermatol 18:513\u2013528. https:\/\/doi.org\/10.1007\/s40257-017-0264-2","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"5993_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40257-023-00832-1","volume":"25","author":"M Karakioulaki","year":"2024","unstructured":"Karakioulaki M, Eyerich K, Patsatsi A (2024) Advancements in bullous pemphigoid treatment: a comprehensive pipeline update. Am J Clin Dermatol 25(2):195\u2013212. https:\/\/doi.org\/10.1007\/s40257-023-00832-1","journal-title":"Am J Clin Dermatol"},{"key":"5993_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/bjd\/ljad369","volume":"190","author":"R Chebani","year":"2024","unstructured":"Chebani R, Lombart F, Chaby G, Dadban A, Debarbieux S, Viguier M-A et al (2024) Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a french national multicentre retrospective study of 100 patients. Br J Dermatol 190:258\u2013265. https:\/\/doi.org\/10.1093\/bjd\/ljad369","journal-title":"Br J Dermatol"},{"key":"5993_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamadermatol.2023.4508","volume":"160","author":"ST Le","year":"2024","unstructured":"Le ST, Herbert S, Haughton R, Nava J, Toussi A, Ji-Xu A et al (2024) Rituximab and omalizumab combination therapy for bullous pemphigoid. JAMA Dermatol 160:107\u2013109. https:\/\/doi.org\/10.1001\/jamadermatol.2023.4508","journal-title":"JAMA Dermatol"},{"key":"5993_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamadermatol.2023.2428","volume":"159","author":"L Zhao","year":"2023","unstructured":"Zhao L, Wang Q, Liang G, Zhou Y, Yiu N, Yang B et al (2023) Evaluation of dupilumab in patients with bullous pemphigoid. JAMA Dermatol 159:953\u2013960. https:\/\/doi.org\/10.1001\/jamadermatol.2023.2428","journal-title":"JAMA Dermatol"},{"key":"5993_CR9","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","volume":"137","author":"Y Liu","year":"2017","unstructured":"Liu Y, Peng L, Li L, Liu C, Hu X, Xiao S et al (2017) TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid. J Invest Dermatol 137:1512\u20131522. https:\/\/doi.org\/10.1016\/j.jid.2017.03.019","journal-title":"J Invest Dermatol"},{"key":"5993_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jid.2018.05.036","volume":"139","author":"J Liu","year":"2019","unstructured":"Liu J, Liu Y, Peng L, Li J, Wu K, Xia L et al (2019) TWEAK\/Fn14 signals mediate burn wound repair. J Invest Dermatol 139:224\u2013234. https:\/\/doi.org\/10.1016\/j.jid.2018.05.036","journal-title":"J Invest Dermatol"},{"key":"5993_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13287-022-02930-z","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Li L, Cook C, Zhang Y, Xia Y, Liu Y (2022) A potential fate decision landscape of the TWEAK\/Fn14 axis on stem and progenitor cells: a systematic review. Stem Cell Res Ther 13:270. https:\/\/doi.org\/10.1186\/s13287-022-02930-z","journal-title":"Stem Cell Res Ther"},{"key":"5993_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10238-014-0279-4","volume":"15","author":"M Sisto","year":"2015","unstructured":"Sisto M, Lisi S, D\u2019Amore M, Lofrumento DD (2015) The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in sj\u00f6gren\u2019s syndrome. Clin Exp Med 15:215\u2013225. https:\/\/doi.org\/10.1007\/s10238-014-0279-4","journal-title":"Clin Exp Med"},{"key":"5993_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq7074","volume":"16","author":"Q You","year":"2024","unstructured":"You Q, Chen L, Li S, Liu M, Tian M, Cheng Y et al (2024) Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humans. Sci Transl Med 16:eabq7074. https:\/\/doi.org\/10.1126\/scitranslmed.abq7074","journal-title":"Sci Transl Med"},{"key":"5993_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/08977194.2014.952410","volume":"32","author":"SLJ Knudsen","year":"2014","unstructured":"Knudsen SLJ, Mac ASW, Henriksen L, van Deurs B, Gr\u00f8vdal LM (2014) EGFR signaling patterns are regulated by its different ligands. Growth Factors 32:155\u2013163. https:\/\/doi.org\/10.3109\/08977194.2014.952410","journal-title":"Growth Factors"},{"key":"5993_CR15","doi-asserted-by":"publisher","first-page":"L731","DOI":"10.1152\/ajplung.00309.2014","volume":"308","author":"K Brune","year":"2015","unstructured":"Brune K, Frank J, Schwingshackl A, Finigan J, Sidhaye VK (2015) Pulmonary epithelial barrier function: some new players and mechanisms. Am J Physiol Lung Cell Mol Physiol 308:L731\u2013L745. https:\/\/doi.org\/10.1152\/ajplung.00309.2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5993_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/15419061.2012.748326","volume":"19","author":"A Buda","year":"2012","unstructured":"Buda A, Jepson MA, Pignatelli M (2012) Regulatory function of trefoil peptides (TFF) on intestinal cell junctional complexes. Cell Commun Adhes 19:63\u201368. https:\/\/doi.org\/10.3109\/15419061.2012.748326","journal-title":"Cell Commun Adhes"},{"key":"5993_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s0923-1811(96)00567-1","volume":"14","author":"N Hatta","year":"1997","unstructured":"Hatta N, Takata M, Kawara S, Hirone T, Takehara K (1997) Tape stripping induces marked epidermal proliferation and altered TGF-alpha expression in non-lesional psoriatic skin. J Dermatol Sci 14:154\u2013161. https:\/\/doi.org\/10.1016\/s0923-1811(96)00567-1","journal-title":"J Dermatol Sci"},{"key":"5993_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0002-9440(10)63654-1","volume":"163","author":"F Mascia","year":"2003","unstructured":"Mascia F, Mariani V, Girolomoni G, Pastore S (2003) Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 163:303\u2013312. https:\/\/doi.org\/10.1016\/S0002-9440(10)63654-1","journal-title":"Am J Pathol"},{"key":"5993_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF01213299","volume":"32","author":"S Koyama","year":"1997","unstructured":"Koyama S, Ikeda K, Sato M, Shibahara K, Yuhara K, Fukutomi H et al (1997) Transforming growth factor-alpha (TGF\u202f?-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF\u202f? in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol 32:71\u201377. https:\/\/doi.org\/10.1007\/BF01213299","journal-title":"J Gastroenterol"},{"key":"5993_CR20","doi-asserted-by":"publisher","first-page":"29286","DOI":"10.18632\/oncotarget.25389","volume":"9","author":"RMC Ignacio","year":"2028","unstructured":"Ignacio RMC, Gibbs CR, Lee E-S, Son D-S (2028) The TGF\u03b1-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells. Oncotarget 9:29286\u201329303. https:\/\/doi.org\/10.18632\/oncotarget.25389","journal-title":"Oncotarget"},{"key":"5993_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910260","volume":"22","author":"C Stefani","year":"2021","unstructured":"Stefani C, Miricescu D, Stanescu-Spinu I-I, Nica RI, Greabu M, Totan AR et al (2021) Growth factors, PI3K\/AKT\/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: where are we now? Int J Mol Sci 22:10260. https:\/\/doi.org\/10.3390\/ijms221910260","journal-title":"Int J Mol Sci"},{"key":"5993_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrneph.2016.91","volume":"12","author":"LR Harskamp","year":"2016","unstructured":"Harskamp LR, Gansevoort RT, van Goor H, Meijer E (2016) The epidermal growth factor receptor pathway in chronic kidney diseases. Nat Rev Nephrol 12:496\u2013506. https:\/\/doi.org\/10.1038\/nrneph.2016.91","journal-title":"Nat Rev Nephrol"},{"key":"5993_CR23","doi-asserted-by":"crossref","unstructured":"Nystr\u00f6m A, Kiritsi D, Bruckner-Tuderman L (2021) Skin blistering and collagens: from bench to therapies. In: Ruggiero F (ed) The collagen superfamily and collagenopathies. Springer, pp 257\u2013288","DOI":"10.1007\/978-3-030-67592-9_7"},{"key":"5993_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.autrev.2019.03.009","volume":"18","author":"EH Kowalski","year":"2019","unstructured":"Kowalski EH, Kneibner D, Kridin K, Amber KT (2019) Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev 18:526\u2013534. https:\/\/doi.org\/10.1016\/j.autrev.2019.03.009","journal-title":"Autoimmun Rev"},{"key":"5993_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000090385","volume":"139","author":"Y Niimi","year":"2006","unstructured":"Niimi Y, Pawankar R, Kawana S (2006) Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid. Int Arch Allergy Immunol 139:104\u2013113. https:\/\/doi.org\/10.1159\/000090385","journal-title":"Int Arch Allergy Immunol"},{"key":"5993_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaci.2016.08.012","volume":"139","author":"M Riani","year":"2017","unstructured":"Riani M, Le Jan S, Pl\u00e9e J, Durlach A, Le Naour R, Haegeman G et al (2017) Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. J Allergy Clin Immunol 139:863-872.e3. https:\/\/doi.org\/10.1016\/j.jaci.2016.08.012","journal-title":"J Allergy Clin Immunol"},{"key":"5993_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fimmu.2017.00651","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Xu M, Min X, Wu K, Zhang T, Li K et al (2017) TWEAK\/Fn14 activation participates in Ro52-mediated photosensitization in cutaneous lupus erythematosus. Front Immunol 8:651. https:\/\/doi.org\/10.3389\/fimmu.2017.00651","journal-title":"Front Immunol"},{"key":"5993_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2013.05.011","volume":"336","author":"M-Q Gao","year":"2013","unstructured":"Gao M-Q, Kim BG, Kang S, Choi YP, Yoon J-H, Cho NH (2013) Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-\u03b1 cleavage by ADAM17. Cancer Lett 336:240\u2013246. https:\/\/doi.org\/10.1016\/j.canlet.2013.05.011","journal-title":"Cancer Lett"},{"key":"5993_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1084\/jem.20112258","volume":"209","author":"C-W Franzke","year":"2012","unstructured":"Franzke C-W, Cobzaru C, Triantafyllopoulou A, L\u00f6ffek S, Horiuchi K, Threadgill DW et al (2012) Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med 209:1105\u20131119. https:\/\/doi.org\/10.1084\/jem.20112258","journal-title":"J Exp Med"},{"key":"5993_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12016-023-08973-1","volume":"65","author":"H-C Chen","year":"2023","unstructured":"Chen H-C, Wang C-W, Toh WH, Lee H-E, Chung W-H, Chen C-B (2023) Advancing treatment in bullous pemphigoid: a comprehensive review of novel therapeutic targets and approaches. Clin Rev Allergy Immunol 65:331\u2013353. https:\/\/doi.org\/10.1007\/s12016-023-08973-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"5993_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.forsciint.2004.08.021","volume":"153","author":"W Grellner","year":"2005","unstructured":"Grellner W, Vieler S, Madea B (2005) Transforming growth factors (TGF-alpha and TGF-beta1) in the determination of vitality and wound age: immunohistochemical study on human skin wounds. Forensic Sci Int 153:174\u2013180. https:\/\/doi.org\/10.1016\/j.forsciint.2004.08.021","journal-title":"Forensic Sci Int"},{"key":"5993_CR32","first-page":"1307","volume":"138","author":"R Todd","year":"1991","unstructured":"Todd R, Donoff BR, Chiang T, Chou MY, Elovic A, Gallagher GT et al (1991) The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am J Pathol 138:1307\u20131313","journal-title":"Am J Pathol"},{"key":"5993_CR33","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/biom11101506","volume":"11","author":"N Cirillo","year":"2021","unstructured":"Cirillo N, Prime SS (2021) A scoping review of the role of metalloproteinases in the pathogenesis of autoimmune pemphigus and pemphigoid. Biomolecules 11:1506. https:\/\/doi.org\/10.3390\/biom11101506","journal-title":"Biomolecules"},{"key":"5993_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.matbio.2015.03.002","volume":"44\u201346","author":"MG Rohani","year":"2015","unstructured":"Rohani MG, Parks WC (2015) Matrix remodeling by MMPs during wound repair. Matrix Biol 44\u201346:113\u2013121. https:\/\/doi.org\/10.1016\/j.matbio.2015.03.002","journal-title":"Matrix Biol"},{"key":"5993_CR35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1478-3231.2011.02475.x","volume":"31","author":"T Ohyama","year":"2011","unstructured":"Ohyama T, Yamazaki Y, Sato K, Horiguchi N, Ichikawa T, Kakizaki S et al (2011) Transforming growth factor-\u03b1 attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1. Liver Int 31:572\u2013584. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02475.x","journal-title":"Liver Int"},{"key":"5993_CR36","doi-asserted-by":"publisher","first-page":"2280991","DOI":"10.1080\/07853890.2023.2280991","volume":"55","author":"R Huang","year":"2023","unstructured":"Huang R, Hu L, Jiang F (2023) Study of cytokine-induced immunity in bullous pemphigoid: recent developments. Ann Med 55:2280991. https:\/\/doi.org\/10.1080\/07853890.2023.2280991","journal-title":"Ann Med"},{"key":"5993_CR37","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/exd.13779","volume":"27","author":"K Tanita","year":"2018","unstructured":"Tanita K, Fujimura T, Sato Y, Lyu C, Aiba S (2018) Minocycline decreases Th2 chemokines from M2 macrophages: possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs. Exp Dermatol 27:1268\u20131272. https:\/\/doi.org\/10.1111\/exd.13779","journal-title":"Exp Dermatol"},{"key":"5993_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2133.2006.07601.x","volume":"156","author":"H Nakashima","year":"2007","unstructured":"Nakashima H, Fujimoto M, Asashima N, Watanabe R, Kuwano Y, Yazawa N et al (2007) Serum chemokine profile in patients with bullous pemphigoid. Br J Dermatol 156:454\u2013459. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07601.x","journal-title":"Br J Dermatol"},{"key":"5993_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00271","volume":"5","author":"PT Kuo","year":"2018","unstructured":"Kuo PT, Zeng Z, Salim N, Mattarollo S, Wells JW, Leggatt GR (2018) The role of CXCR3 and its chemokine ligands in skin disease and cancer. Front Med 5:271. https:\/\/doi.org\/10.3389\/fmed.2018.00271","journal-title":"Front Med"},{"key":"5993_CR40","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/jcp.22548","volume":"226","author":"A De Luca","year":"2011","unstructured":"De Luca A, Gallo M, Aldinucci D, Ribatti D, Lamura L, D\u2019Alessio A et al (2011) Role of the EGFR ligand\/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J Cell Physiol 226:2131\u20132138. https:\/\/doi.org\/10.1002\/jcp.22548","journal-title":"J Cell Physiol"},{"key":"5993_CR41","first-page":"207","volume":"14","author":"M Berg","year":"2012","unstructured":"Berg M, Soreide K (2012) EGFR and downstream genetic alterations in KRAS\/BRAF and PI3K\/AKT pathways in colorectal cancer: implications for targeted therapy. Discov Med 14:207\u2013214","journal-title":"Discov Med"},{"key":"5993_CR42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cellsig.2011.10.001","volume":"24","author":"ME D\u00edaz","year":"2012","unstructured":"D\u00edaz ME, Gonz\u00e1lez L, Miquet JG, Mart\u00ednez CS, Sotelo AI, Bartke A et al (2012) Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver. Cell Signal 24:514\u2013523. https:\/\/doi.org\/10.1016\/j.cellsig.2011.10.001","journal-title":"Cell Signal"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05993-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05993-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05993-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:21:55Z","timestamp":1767061315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05993-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5993"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05993-2","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Xi\u2019an Jiaotong University, approval number 2024YS017.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent prior to inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"18"}}